MedTrace Logo

HFNC and Prone Positioning in Awake Patients With Severe COVID-19

NCT04982341 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2021-07-29

No results posted yet for this study

Summary

The investigators evaluate the effects of High-flow nasal cannula (HFNC) in association with prone in patients with Covid-19 severe ARF.

Conditions

  • Hypoxemic Respiratory Failure

Interventions

PROCEDURE

prone position

patients are returned from prone to supine position while receiving oxygenation through HFNC

Sponsors & Collaborators

  • Hôpital Universitaire Fattouma Bourguiba

    lead OTHER

Principal Investigators

  • Lamia Besbes, Prof · CPPRB

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-02
Primary Completion
2021-03-03
Completion
2021-03-03

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04982341 on ClinicalTrials.gov